Literature DB >> 3708932

Morphology of cyclosporine nephrotoxicity in the rat.

M J Mihatsch, B Ryffel, M Hermle, F P Brunner, G Thiel.   

Abstract

Cyclosporine (CSA) nephrotoxicity was investigated in the rat. Morphologically, CSA nephrotoxicity is characterized by the following features: (a) Tubular inclusion bodies (TIB) corresponding to autolysosomes and giant mitochondria; (b) tubular vacuolization (TV) due to dilatation of the endoplasmatic reticulum; (c) tubular microcalcification (TM); and (d) tubular regeneration (TR). The morphologic features are limited to (a and b) or predominate (c and d) in the proximal tubule. CSA tubulopathy as defined above is dose dependent, independent of the route of a drug administration, develops quickly (within a week), is reversible after CSA withdrawal, is more pronounced in male than in female rats and shows no clear cut differences in various rat strains. Body weight shows a dose dependent reduction. The functional changes are usually slight. No significant correlation exists between functional changes and morphologic lesions. The type of CSA nephrotoxicity in the rat is very similar to CSA-tubulopathy in man but associated with less severe functional changes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708932

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

1.  Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats.

Authors:  S Koehn; F J Frey; R F Speck; T Zeugin; T Schaffner; A Zimmermann; B M Frey
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

Review 2.  Isolated glomeruli and cultured mesangial cells as in vitro models to study immunosuppressive agents.

Authors:  M Potier; B L'Azou; J Cambar
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

3.  Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney.

Authors:  Zsuzsanna K Zsengellér; Nika Aljinovic; Lisa A Teot; Mark Korson; Nancy Rodig; Jennifer L Sloan; Charles P Venditti; Gerard T Berry; Seymour Rosen
Journal:  Pediatr Nephrol       Date:  2014-05-28       Impact factor: 3.714

4.  [Eulogy to Prof. Dr. Med. Michael J. Mihatsch : Presentation of the Rudolf Virchow Medal 2019 of the German Society of Pathology].

Authors:  H Moch
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

5.  Influence of enalapril on experimental cyclosporin A nephrotoxicity.

Authors:  A Anarat; A Noyan; G Gonlusen; N Duman; D Tuncer
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

Review 6.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

Review 7.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

8.  Renal injury induced by long-term administration of cyclosporin A to rats.

Authors:  T Bertani; N Perico; M Abbate; C Battaglia; G Remuzzi
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

9.  Functional effects on glomerular hemodynamics of short-term chronic cyclosporine in male rats.

Authors:  S C Thomson; B J Tucker; F Gabbai; R C Blantz
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

10.  Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.

Authors:  P H Whiting; N Barnard; A Neilsch; J G Simpson; M D Burke
Journal:  Br J Exp Pathol       Date:  1987-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.